Warning Letter Wednesday Posts
A weekly exploration of FDA warning letters and enforcement trends
Takeaway -
Test “sketchy” products for adulterants
Takeaway -
Small business learning lessons
Takeaway -
Hashtags elevate marketing risk
Takeaway -
Ensure substantiation is suitable for each claim
Takeaway -
Comparison to drugs is high risk
Takeaway -
Product names are marketing
Takeaway -
Ensure weight loss products are tested for drugs
Takeaway -
“Arthritis” claims elevate risk
Takeaway -
Ensure ingredients are lawful for supplements
Takeaway -
Re-review marketing if FDA has inspected you
Takeaway -
All claims should be substantiated
Takeaway -
All dietary ingredients must be tested for identity